UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Depression and anxiety among College Students in Slovakia - Comparison of the Year 2018 and during COVID-19 pandemic

Bratislavské lékarské listy, 2022-01, Vol.123 (1), p.44-49

2022

Volltextzugriff (PDF)

Prevalence and correlations of depression and anxiety among Slovak college students

Bratislavské lékarské listy, 2019, Vol.120 (9), p.695-698

2019

Volltextzugriff (PDF)

P.3.b.032 Evaluation of preferences of chimeric, reversed and normal self-face in patients with schizophrenia and healthy controls – a pilot study

European neuropsychopharmacology, 2014-10, Vol.24, p.S509-S510

2014

Volltextzugriff (PDF)

P.3.b.019 Will schizoaffective disorder survive the era of DSM-5?

European neuropsychopharmacology, 2015-09, Vol.25, p.S474-S474

2015

Volltextzugriff (PDF)

Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients

International journal of clinical practice (Esher), 2009-11, Vol.63 (11), p.1578-1588

2009

Volltextzugriff (PDF)

Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry

Current medical research and opinion, 2009-09, Vol.25 (9), p.2197-2206

2009

Volltextzugriff (PDF)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]

Neuropsychiatric disease and treatment, 2013-01, Vol.9 (default), p.1827-1827

Pecenak, Jan

2013

Volltextzugriff (PDF)

Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries

Current medical research and opinion, 2010-03, Vol.26 (3), p.501-509

2010

Volltextzugriff (PDF)

P-1284 - Analysis of one-year prescription of antipsychotics and rate of rehospitalizations in patients with schizophrenia spectrum disorders in slovakia

European psychiatry, 2012, Vol.27, p.1-1

2012

Volltextzugriff (PDF)

EPID and EPIA - the first epidemiological studies on depression and anxiety disorders in Slovakia

Journal of affective disorders, 2010-04, Vol.122, p.S56-S56

2010

Volltextzugriff (PDF)

2696 – Functional capacity and subjective satisfaction with medication in schizophrenia patients

European psychiatry, 2013, Vol.28, p.1-1

2013

Volltextzugriff (PDF)

P.3.c.005 Assessment of functional capacity of schizophrenia patients in the Czech and Slovak Republics: a cross-sectional study

European neuropsychopharmacology, 2011, Vol.21, p.S470-S470

2011

Volltextzugriff (PDF)

Schizophrenia and Negative Symptoms – Burden of the Disease in Seven Central and Eastern European (CEE) Countries: THE Results of the Literature Review

Value in health, 2013-11, Vol.16 (7), p.A545-A546

2013

Volltextzugriff (PDF)

33 – Reduction in suicidal ideation, violent behaviour and self-injury after treatment with risperidone long-acting injection

Schizophrenia research, 2008-02, Vol.98, p.47-47

2008

Volltextzugriff (PDF)

P.3.c.029 Results from the monitoring system for clozapine in Slovakia

European neuropsychopharmacology, 2009, Vol.19, p.S527-S527

2009

Volltextzugriff (PDF)

c-Fos expression response to olanzapine, amisulpride, quetiapine, and aripiprazole in the rat forebrain and effect of a mild stress preconditioning

European neuropsychopharmacology, 2019, Vol.29, p.S393-S393

2019

Volltextzugriff (PDF)

P.036 Cannabis use in university students and its associations to depression, anxiety, and psychotic-like experiences

European neuropsychopharmacology, 2020-11, Vol.40, p.S24-S25

2020

Volltextzugriff (PDF)

Psychiatry in selected countries of Central and Eastern Europe: an overview of the current situation

Acta psychiatrica Scandinavica, 2006-10, Vol.114 (4), p.223-231

2006

Volltextzugriff (PDF)

P03-303 - Improvement in patient symptoms and functioning during long-term treatment with olanzapine long-acting injection (OLAI)

European psychiatry, 2011, Vol.26, p.1473-1473

2011

Volltextzugriff (PDF)

EPIA-epidemiology of Gad and Sad in Slovakia

European psychiatry, 2007-03, Vol.22, p.S329-S329

2007

Volltextzugriff (PDF)

SUICIDAL IDEATION, VIOLENT BEHAVIOR, AND SELF-INJURY IN SCHIZOPHRENIA PATIENTS TREATED WITH LONG ACTING RISPERIDONE: 12-MONTH RESULTS FROM E-STAR

Schizophrenia research, 2008, Vol.102 (1), p.276-276

2008

Volltextzugriff (PDF)

RISPERIDONE LONG ACTING INJECTION TREATMENT IN SCHIZOPHRENIA: 12-MONTH RESULTS FROM THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY (E-STAR)

Schizophrenia research, 2008, Vol.102 (1), p.260-260

2008

Volltextzugriff (PDF)

Agomelatine as monotherapy for major depression: an outpatient, open-label study

Neuropsychiatric disease and treatment, 2013-01, Vol.9 (default), p.1595-1604

2013

Volltextzugriff (PDF)

P.3.c.052 Risperidone long-acting injection in the treatment of recently versus longer diagnosed patients with schizophrenia

European neuropsychopharmacology, 2008, Vol.18, p.S434-S434

2008

Volltextzugriff (PDF)

Theory of mind and its relationship to subjective and clinician-rated functional outcome in patients with schizophrenia

European neuropsychopharmacology, 2016-10, Vol.26, p.S590-S591

2016

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(58)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Psychiatry
(22)
Internal Medicine
(18)
Science & Technology
(16)
Life Sciences & Biomedicine
(13)
Humans
(12)
Female
(8)
Male
(7)
Adult
(5)
General & Internal Medicine
(5)
Medicine, General & Internal
(5)
Neurosciences & Neurology
(5)
Schizophrenia
(5)
Depression
(4)
Prospective Studies
(4)
Schizophrenia - Drug Therapy
(4)
Antipsychotic Agents - Adverse Effects
(3)
Antipsychotic Agents - Therapeutic Use
(3)
Clinical Neurology
(3)
Distribution System
(3)
Engineering
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Depression and anxiety among College Students in Slovakia - Comparison of the Year 2018 and during COVID-19 pandemic

Prevalence and correlations of depression and anxiety among Slovak college students

P.3.b.032 Evaluation of preferences of chimeric, reversed and normal self-face in patients with schizophrenia and healthy controls – a pilot study

P.3.b.019 Will schizoaffective disorder survive the era of DSM-5?

Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients

Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]

Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries

P-1284 - Analysis of one-year prescription of antipsychotics and rate of rehospitalizations in patients with schizophrenia spectrum disorders in slovakia

EPID and EPIA - the first epidemiological studies on depression and anxiety disorders in Slovakia

2696 – Functional capacity and subjective satisfaction with medication in schizophrenia patients

P.3.c.005 Assessment of functional capacity of schizophrenia patients in the Czech and Slovak Republics: a cross-sectional study

Schizophrenia and Negative Symptoms – Burden of the Disease in Seven Central and Eastern European (CEE) Countries: THE Results of the Literature Review

33 – Reduction in suicidal ideation, violent behaviour and self-injury after treatment with risperidone long-acting injection

P.3.c.029 Results from the monitoring system for clozapine in Slovakia

c-Fos expression response to olanzapine, amisulpride, quetiapine, and aripiprazole in the rat forebrain and effect of a mild stress preconditioning

P.036 Cannabis use in university students and its associations to depression, anxiety, and psychotic-like experiences

Psychiatry in selected countries of Central and Eastern Europe: an overview of the current situation

P03-303 - Improvement in patient symptoms and functioning during long-term treatment with olanzapine long-acting injection (OLAI)

EPIA-epidemiology of Gad and Sad in Slovakia

SUICIDAL IDEATION, VIOLENT BEHAVIOR, AND SELF-INJURY IN SCHIZOPHRENIA PATIENTS TREATED WITH LONG ACTING RISPERIDONE: 12-MONTH RESULTS FROM E-STAR

RISPERIDONE LONG ACTING INJECTION TREATMENT IN SCHIZOPHRENIA: 12-MONTH RESULTS FROM THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY (E-STAR)

Agomelatine as monotherapy for major depression: an outpatient, open-label study

P.3.c.052 Risperidone long-acting injection in the treatment of recently versus longer diagnosed patients with schizophrenia

Theory of mind and its relationship to subjective and clinician-rated functional outcome in patients with schizophrenia

Suchergebnisse filtern